ID: ALA3887058
Type: Binding
Description: Cell Free Inhibition Assay: The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by determining the concentration of inhibitor at which 50% of the nitrocefin hydrolysis is inhibited by the particular enzyme. Assays are performed with beta -lactamases expressed in the pET system (Novagen, San Diego, Calif.) without signal peptides. They contain an N-terminal hexa-Histidine tag that is used for purification on Ni-NTA (Qiagen, Hilden, Germany). The compounds are prepared as 50 mM stocks in DMSO and diluted into buffer P1 (50 mM phosphate, pH 7) to a final concentration of 10% DMSO. All further dilutions are done in P2 (P1 with 10% DMSO). Enzyme and compound dilutions are pre-incubated for 10 min at 37 C. and the reaction is started with the addition of pre-warmed (37 C.) nitrocefin at a final concentration of 50 mM. The change in absorption at 490 nm is followed at 37 C. for 10 min with 30 s intervals.
Bioactivity
Activity Types for Assay ALA3887058
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
233.24 | -0.79 | -0.79 |
300.30 | -1.52 | -1.52 |
199.16 | -1.10 | -1.10 |
403.43 | 3.24 | 3.24 |
327.34 | 1.67 | 1.67 |
427.45 | 2.59 | 2.59 |
253.21 | -0.38 | -0.38 |
384.35 | 1.57 | 1.57 |
393.13 | 0.12 | 0.12 |
343.34 | 1.28 | 1.28 |
327.34 | 1.67 | 1.67 |
253.21 | -0.38 | -0.38 |
359.38 | 1.57 | 1.57 |
357.36 | 1.08 | 1.08 |
455.25 | 2.17 | 2.17 |
443.45 | 2.48 | 2.48 |
345.35 | 1.48 | 1.48 |
343.34 | 1.56 | 1.56 |
596.64 | 4.81 | 4.81 |
343.34 | 1.60 | 1.60 |
357.36 | 1.08 | 1.08 |
267.24 | 0.03 | 0.03 |
255.23 | 0.17 | 0.17 |
419.43 | 3.13 | 3.13 |
269.25 | 0.26 | 0.26 |
251.24 | 0.15 | 0.15 |
251.24 | 0.15 | 0.15 |
343.34 | 1.56 | 1.56 |
469.23 | 1.69 | 1.69 |
419.43 | 3.13 | 3.13 |
329.35 | 1.51 | 1.51 |
405.45 | 3.04 | 3.04 |
427.45 | 2.59 | 2.59 |